Filing Details
- Accession Number:
- 0000950103-20-016184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-20 16:22:16
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-20 16:22:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1642545 | Shockwave Medical Inc. | SWAV | () | I0 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1616320 | Fcpr Vii Capital Sofinnova | C/O Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara CA 95054 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-08-17 | 61,823 | $55.04 | 2,218,006 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-18 | 133,922 | $55.08 | 2,084,084 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-19 | 18,720 | $55.37 | 2,065,364 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-19 | 40,720 | $56.79 | 2,024,644 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-19 | 30,438 | $57.08 | 1,994,206 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares held by the reporting person are also reported on Form 4 by Antoine Papiernik, one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of the reporting person. Mr. Papiernik disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $56.00 to $56.9989. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $57.00 to $57.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.